Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yanjun Zhang, Lu Chen, Zhonghua Wang, Yiren Zhu, Huifang Jiang, Jie Xu & Fei Xiong. (2023) Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Read now
H. R. Xu, L. Fu, P. Zhan & X. Y. Liu. (2016) 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA. SAR and QSAR in Environmental Research 27:12, pages 999-1014.
Read now
Read now
Osmond J D'Cruz & Fatih M Uckun. (2014) Vaginal microbicides and their delivery platforms. Expert Opinion on Drug Delivery 11:5, pages 723-740.
Read now
Read now
Osmond J D'Cruz, Sanjive Qazi, Seang Yiv & Fatih M Uckun. (2012) A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea]). Expert Opinion on Investigational Drugs 21:3, pages 265-279.
Read now
Read now
Articles from other publishers (15)
Svitlana I. Orysyk, Yurii L. Zborovskii, Viktor V. Orysyk, Liudmyla V. Garmanchuk, Polina V. Borovyk, Svitlana V. Shishkina, Olha Pavliuk, Vasyl I. Pekhnyo & Mykhailo V. Vovk. (2023) Synthesis, structural and spectral characteristics of novel n,π-chelate complexes of Pd(II) and Pt(II) with N-allylthioureas and their influence on the growth of spheroids cells MCF-7 and GGT activity. Polyhedron 231, pages 116272.
Crossref
Crossref
Anastasia Khandazhinskaya, Elena Matyugina & Mikhail Novikov. 2021. Coronaviruses and other Novel Antiviral Targets. Coronaviruses and other Novel Antiviral Targets
175
238
.
Yumeng Wu, Chengrun Tang, Ruomei Rui, Liumeng Yang, Wei Ding, Jiangyuan Wang, Yiming Li, Christopher C. Lai, Yueping Wang, Ronghua Luo, Weilie Xiao, Hongbing Zhang, Yongtang Zheng & Yanping He. (2020) Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors. Acta Pharmaceutica Sinica B 10:3, pages 512-528.
Crossref
Crossref
Lokendra Kumar Ojha. Mathematical modeling of tetrahydroimidazole benzodiazepine-1-one derivatives as an anti HIV agent. Mathematical modeling of tetrahydroimidazole benzodiazepine-1-one derivatives as an anti HIV agent.
Osmond D'Cruz & Fatih Uckun. 2014. Drug Delivery and Development of Anti-HIV Microbicides. Drug Delivery and Development of Anti-HIV Microbicides
1
54
.
Nagy M. Khalifa, Erik B. Pedersen, Claus Nielsen & Mohamed A. Al-Omar. (2014) Synthesis and evaluation of novel 6-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents. Russian Journal of Bioorganic Chemistry 40:5, pages 579-585.
Crossref
Crossref
Peng Zhan, Xuwang Chen, Dongyue Li, Zengjun Fang, Erik De Clercq & Xinyong Liu. (2013) HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design. Medicinal Research Reviews 33:S1, pages E1-E72.
Crossref
Crossref
Eugene L. Asahchop, Mark A. Wainberg, Richard D. Sloan & Cécile L. Tremblay. (2012) Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors. Antimicrobial Agents and Chemotherapy 56:10, pages 5000-5008.
Crossref
Crossref
I. A. Novakov, M. Artico, A. Mai, D. Rotili, B. S. Orlinson, L. L. Brunilina & M. B. Nawrozkij. (2013) 6-(Arylmethyl)pyrimidin-4(3H)-ones: anthology and prospects of highly efficient anti-HIV agents. Russian Chemical Bulletin 61:7, pages 1399-1418.
Crossref
Crossref
Marco Radi, Mafalda Pagano, Luigi Franchi, Daniele Castagnolo, Silvia Schenone, Gianni Casaluce, Claudio Zamperini, Elena Dreassi, Giovanni Maga, Alberta Samuele, Encarna Gonzalo, Bonaventura Clotet, José A. Esté & Maurizio Botta. (2012) Synthesis, Biological Activity, and ADME Properties of Novel S-DABOs/N-DABOs as HIV Reverse Transcriptase Inhibitors. ChemMedChem 7:5, pages 883-896.
Crossref
Crossref
Mark A. Wainberg. (2012) The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance. Scientifica 2012, pages 1-28.
Crossref
Crossref
Mingyan Yu, Zhenyu Li, Shuai Liu, Erkang Fan, Christophe Pannecouque, Erik De Clercq & Xinyong Liu. (2011) Synthesis and Biological Evaluation of 6-Substituted 5-Alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as Potent HIV-1 NNRTIs. ChemMedChem 6:5, pages 826-833.
Crossref
Crossref
Yan-Ping He, Jin Long, Shui-Shuan Zhang, Cong Li, Christopher Cong Lai, Chun-Sheng Zhang, Da-Xiong Li, De-Hua Zhang, Hua Wang, Qing-Qing Cai & Yong-Tang Zheng. (2011) Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents. Bioorganic & Medicinal Chemistry Letters 21:2, pages 694-697.
Crossref
Crossref
Monique Araújo de BritoCarlos Rangel RodriguesJosé Jair Vianna CirinoRicardo Bicca de AlencastroHelena Carla CastroMagaly Girão Albuquerque. (2008) 3D-QSAR CoMFA of a Series of DABO Derivatives as HIV-1 Reverse Transcriptase Non-Nucleoside Inhibitors. Journal of Chemical Information and Modeling 48:8, pages 1706-1715.
Crossref
Crossref
Osmond J. D'Cruz & Fatih M. Uckun. (2007) Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1. Fertility and Sterility 88:4, pages 1197-1206.
Crossref
Crossref